Literature DB >> 8551032

Internalization of human macrophage surface antigens induced by monoclonal antibodies.

R Audran1, B Drenou, F Wittke, A Gaudin, T Lesimple, L Toujas.   

Abstract

Drugs intended to be endocytosed by macrophages may be transported by MAbs directed against these cells. Twenty MAbs were investigated for this purpose. The binding of these MAbs to macrophages obtained from a 7 day culture of blood monocytes showed that anti-CD11b and anti-CD14 recognized the highest number of cell surface antigen sites. Further assays determined that anti-CD63, Mo5 and anti-CD33 were the MAbs that induced the strongest modulation of the corresponding antigens, the highest rate being with anti-CD63. Endocytosis of antigen-antibody complexes was evidenced by the presence of MAbs in the cytoplasm. Anti-CD63 MAbs induced the highest internalization in this assay. For most MAbs, however, the density of antigen sites and the intensity of antigen modulation were not predictive of the amount of MAb detected in the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8551032     DOI: 10.1016/0022-1759(95)00213-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Distinct roles for tetraspanins CD9, CD63 and CD81 in the formation of multinucleated giant cells.

Authors:  Varadarajan Parthasarathy; Francine Martin; Adrian Higginbottom; Helen Murray; Gregory W Moseley; Robert C Read; Gorakh Mal; Rachel Hulme; Peter N Monk; Lynda J Partridge
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

2.  Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion Protein.

Authors:  A Leemans; M De Schryver; W Van der Gucht; A Heykers; I Pintelon; A L Hotard; M L Moore; J A Melero; J S McLellan; B S Graham; L Broadbent; U F Power; G Caljon; P Cos; L Maes; P Delputte
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

3.  Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptides.

Authors:  L Toujas; J G Delcros; E Diez; N Gervois; G Semana; G Corradin; F Jotereau
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

4.  Porcine sialoadhesin (CD169/Siglec-1) is an endocytic receptor that allows targeted delivery of toxins and antigens to macrophages.

Authors:  Peter L Delputte; Hanne Van Gorp; Herman W Favoreel; Inge Hoebeke; Iris Delrue; Hannah Dewerchin; Frank Verdonck; Bruno Verhasselt; Eric Cox; Hans J Nauwynck
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240

Review 5.  Siglecs as targets for therapy in immune-cell-mediated disease.

Authors:  Mary K O'Reilly; James C Paulson
Journal:  Trends Pharmacol Sci       Date:  2009-04-07       Impact factor: 14.819

Review 6.  Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin.

Authors:  Andrew J Cowan; George S Laszlo; Elihu H Estey; Roland B Walter
Journal:  Front Biosci (Landmark Ed)       Date:  2013-06-01

7.  Quantification of Antibody Persistence for Cell Surface Protein Labeling.

Authors:  Megan E Dempsey; Olivia Woodford-Berry; Eric M Darling
Journal:  Cell Mol Bioeng       Date:  2021-04-20       Impact factor: 2.321

8.  Targeting CD13 (aminopeptidase-N) in turn downregulates ADAM17 by internalization in acute myeloid leukaemia cells.

Authors:  Sandrine Bouchet; Ruoping Tang; Fanny Fava; Ollivier Legrand; Brigitte Bauvois
Journal:  Oncotarget       Date:  2014-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.